Cliff Asness’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $165M | Sell |
2,266,489
-1,090,054
| -32% | -$70M | 0.06% | 452 |
|
|
2026
Q1 | $186M | Buy |
3,356,543
+193,439
| +6% | +$12.6M | 0.09% | 321 |
|
|
2025
Q4 | $254M | Buy |
3,163,104
+1,034,226
| +49% | +$69.5M | 0.13% | 198 |
|
|
2025
Q3 | $103M | Buy |
2,128,878
+1,678,630
| +373% | +$104M | 0.07% | 409 |
|
|
2025
Q2 | $33.4M | Buy |
450,248
+275,683
| +158% | +$18.3M | 0.03% | 658 |
|
|
2025
Q1 | $10.9M | Buy |
174,565
+149,325
| +592% | +$10.2M | 0.01% | 845 |
|
|
2024
Q4 | $1.95M | Buy |
25,240
+11,240
| +80% | +$903K | ﹤0.01% | 1549 |
|
|
2024
Q3 | $1.13M | Sell |
14,000
-69,988
| -83% | -$5.65M | ﹤0.01% | 1777 |
|
|
2024
Q2 | $6.95M | Sell |
83,988
-44,787
| -35% | -$3.94M | 0.01% | 883 |
|
|
2024
Q1 | $10.9M | Sell |
128,775
-10,143
| -7% | -$796K | 0.02% | 693 |
|
|
2023
Q4 | $11.9M | Sell |
138,918
-57,579
| -29% | -$4.98M | 0.02% | 639 |
|
|
2023
Q3 | $17.6M | Sell |
196,497
-10,584
| -5% | -$945K | 0.04% | 509 |
|
|
2023
Q2 | $17.6M | Buy |
207,081
+57,790
| +39% | +$4.89M | 0.04% | 513 |
|
|
2023
Q1 | $12.3M | Buy |
149,291
+90,092
| +152% | +$7.29M | 0.03% | 613 |
|
|
2022
Q4 | $4.64M | Buy |
59,199
+16,916
| +40% | +$1.36M | 0.01% | 930 |
|
|
2022
Q3 | $3.13M | Buy |
42,283
+34,849
| +469% | +$2.5M | 0.01% | 1008 |
|
|
2022
Q2 | $481K | Sell |
7,434
-18,279
| -71% | -$1.08M | ﹤0.01% | 1695 |
|
|
2022
Q1 | $1.61M | Buy |
25,713
+18,704
| +267% | +$1.02M | ﹤0.01% | 1315 |
|
|
2021
Q4 | $372K | Sell |
7,009
-62,216
| -90% | -$3.79M | ﹤0.01% | 1920 |
|
|
2021
Q3 | $4.89M | Sell |
69,225
-21,870
| -24% | -$1.38M | 0.01% | 816 |
|
|
2021
Q2 | $6.02M | Buy |
91,095
+56,287
| +162% | +$3.98M | 0.01% | 800 |
|
|
2021
Q1 | $3.86M | Sell |
34,808
-22,706
| -39% | -$2.81M | 0.01% | 888 |
|
|
2020
Q4 | $6.82M | Sell |
57,514
-23,527
| -29% | -$2.53M | 0.01% | 708 |
|
|
2020
Q3 | $6.98M | Buy |
81,041
+22,640
| +39% | +$1.98M | 0.01% | 699 |
|
|
2020
Q2 | $5.12M | Buy |
58,401
+14,964
| +34% | +$1.51M | 0.01% | 779 |
|
|
2020
Q1 | $4.33M | Sell |
43,437
-108,264
| -71% | -$11.7M | 0.01% | 826 |
|
|
2019
Q4 | $17.4M | Sell |
151,701
-147,400
| -49% | -$17.8M | 0.02% | 616 |
|
|
2019
Q3 | $37.7M | Sell |
299,101
-372,530
| -55% | -$47.3M | 0.04% | 437 |
|
|
2019
Q2 | $80.2M | Sell |
671,631
-411,879
| -38% | -$40.5M | 0.09% | 265 |
|
|
2019
Q1 | $94.8M | Buy |
1,083,510
+215,054
| +25% | +$19.6M | 0.1% | 236 |
|
|
2018
Q4 | $86.9M | Buy |
868,456
+420,673
| +94% | +$44.2M | 0.1% | 222 |
|
|
2018
Q3 | $51.3M | Buy |
447,783
+270,157
| +152% | +$28M | 0.05% | 380 |
|
|
2018
Q2 | $15.9M | Buy |
177,626
+82,213
| +86% | +$6.94M | 0.02% | 646 |
|
|
2018
Q1 | $6.98M | Buy |
95,413
+84,057
| +740% | +$5.77M | 0.01% | 883 |
|
|
2017
Q4 | $660K | Buy |
11,356
+6,592
| +138% | +$347K | ﹤0.01% | 1821 |
|
|
2017
Q3 | $214K | Buy |
+4,764
| New | +$198K | ﹤0.01% | 2156 |
|
|
2017
Q2 | – | Sell |
-8,202
| Closed | -$333K | – | 2210 |
|
|
2017
Q1 | $333K | Hold |
8,202
| – | – | ﹤0.01% | 1997 |
|
|
2016
Q4 | $330K | Sell |
8,202
-37,687
| -82% | -$1.42M | ﹤0.01% | 2037 |
|
|
2016
Q3 | $1.66M | Buy |
45,889
+2,530
| +6% | +$86.8K | ﹤0.01% | 1502 |
|
|
2016
Q2 | $1.26M | Buy |
+43,359
| New | +$1.31M | ﹤0.01% | 1523 |
|
|
2015
Q4 | – | Sell |
-8,397
| Closed | -$271K | – | 2263 |
|
|
2015
Q3 | $271K | Sell |
8,397
-6,222
| -43% | -$234K | ﹤0.01% | 1956 |
|
|
2015
Q2 | $605K | Buy |
+14,619
| New | +$616K | ﹤0.01% | 1704 |
|
|
2013
Q3 | – | Sell |
-6,200
| Closed | -$256K | – | 2500 |
|
|
2013
Q2 | $256K | Buy |
+6,200
| New | +$251K | ﹤0.01% | 2143 |
|
Other funds holding HAE
AI
RRAM
Cliff Asness's HAE Position: Q2 2026 in Review
Cliff Asness reduced its Haemonetics (HAE) stake by 32% in Q2 2026, selling an estimated $70M and leaving 2,266,489 shares worth $165M. The position accounts for 0.06% of the portfolio, ranked #452.
Cliff Asness first reported a position in HAE in Q2 2013 and has held it in 43 quarters since. The position peaked at $254M in Q4 2025. 327 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Cliff Asness held 2,266,489 shares of Haemonetics worth $165M as of Q2 2026.
- Cliff Asness sold 1,090,054 Haemonetics shares in Q2 2026, an estimated $70M.
- Haemonetics made up 0.06% of Cliff Asness's portfolio in Q2 2026, its #452 holding.
- Cliff Asness first reported a position in Haemonetics in Q2 2013 and has held it in 43 quarters since.
- Cliff Asness's Haemonetics position peaked at $254M in Q4 2025.
- 327 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.